OCT 05, 2021 8:00 AM PDT

Monkey Gene Snares Viruses, Inspires Future Antivirals

WRITTEN BY: Tara Fernandez

Many of the deadly viruses that affect humans—including Ebola and HIV—have animal origins. These infectious agents cross species barriers and establish themselves in their new human hosts with devastating consequences.

Take Ebola, for example. Bats were thought to be the original reservoirs for the viruses, which transmitted the pathogens to other animals, including apes and monkeys. During what's known as a spillover event, humans became infected when they hunted and ate sick animals. Subsequently, outbreaks of Ebola virus disease spread rapidly among vulnerable communities, killing tens of thousands.

In search of new clinical interventions against such infections, virologists are taking a closer look at these viruses' original hosts and making remarkable discoveries. A team of researchers from the University of Utah Health and Rockefeller University teamed up to examine how monkeys' immune systems help resist viral attacks.

The team, led by an evolutionary geneticist, Nels Elde, discovered a monkey gene called retroCHMP3 that acts as a security checkpoint, blocking certain viruses from exiting infected cells. This action prevents the infection from ravaging healthy tissues. The team reported their findings in the journal Cell.

After entering a cell and depositing its genetic material inside, some viruses slip into cell membranes to make a stealthy exit towards neighboring cells. Elde and colleagues discovered that retroCHMP3 stalls the virus' departure, keeping it trapped within the already infected cell.

The team genetically engineered human cells to express a modified version of monkey retroCHMP3. They found that when they infected these engineered cells with HIV, the virus stayed put, unable to bud off and spread. This virus 'trapping' occurred without any observable side effects on normal cell physiology and cell signaling.

According to Elde, this was an unexpected find with important implications on warding off viral infections in humans therapeutically. "We were surprised that slowing down our cell biology just a little bit throws virus replication off its game," Elde commented.

The researchers had previously shown that this viral escape strategy, known as the ESCRT pathway, was the modus operandi of several enveloped viruses. This work led the scientists to hypothesize that cells might adapt to acquire means of defending themselves against viral spreading. The discovery of retroCHMP3 has affirmed their suspicions, paving the way for drugs that mimic this pathway, keeping dangerous viruses localized within the boundaries of already compromised cells.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
SEP 07, 2021
Health & Medicine
Think you can pay back your sleep debt this weekend? Think again.
SEP 07, 2021
Think you can pay back your sleep debt this weekend? Think again.
Researchers find that even one night of sleep loss results in impaired functioning and well being.
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
OCT 12, 2021
Immunology
Cancer Drug Helps Alzheimer's Mice Remember
OCT 12, 2021
Cancer Drug Helps Alzheimer's Mice Remember
What if a drug—specifically developed to treat one disease—had the potential to address other non-related co ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
Loading Comments...